To explore this, we investigated whether four SNPs of the IL-6 gene (rs1818879, rs1554606, rs1800797, and rs1474347) are associated with different levels of CSF pro-inflammatory and anti-inflammatory molecules and clinical presentation in a group of RR-MS patients at the time of diagnosis. This evidence concerns the gene IL6 and myeloid sarcoma.